LFG
MIRM icon

Larson Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Larson Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Buy
141
+6
+4% +$564 ﹤0.01% 2090
2025
Q4 		$10.7K Buy
135
+5
+4% +$359 ﹤0.01% 2086
2025
Q3 		$9.53K Buy
130
+127
+4,233% +$8.07K ﹤0.01% 2040
2025
Q2 		$153 Buy
+3
New +$134 ﹤0.01% 3107

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Larson Financial Group's MIRM Position: Q1 2026 in Review

Larson Financial Group increased its Mirum Pharmaceuticals (MIRM) stake by 4.4% in Q1 2026, buying an estimated $564 and bringing the position to 141 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

Larson Financial Group first reported a position in MIRM in Q2 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Larson Financial Group held 141 shares of Mirum Pharmaceuticals worth $13K as of Q1 2026.
  • Larson Financial Group bought 6 Mirum Pharmaceuticals shares in Q1 2026, an estimated $564.
  • Mirum Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2090 holding.
  • Larson Financial Group first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.